The Filing Desk

Mesa Laboratories vs Maravai LifeSciences

Mesa Laboratories MLAB · Maravai LifeSciences MRVI · Life Sciences Tools & Services

Mesa Laboratories reported revenue of $249 million in fiscal 2026, 1.3 times Maravai LifeSciences' $186 million in fiscal 2025. Mesa Laboratories' revenue grew 3.4% in its latest year, and Maravai LifeSciences' fell 28.3%. Mesa Laboratories had an operating margin of 7.4%, against -115.9% at Maravai LifeSciences. Free cash flow was $40 million at Mesa Laboratories and −$71 million at Maravai LifeSciences. Their fiscal years end in different months (March 31 and December 31), so the periods don't line up exactly.

Side by side

Mesa LaboratoriesMaravai LifeSciences
Latest fiscal yearFY2026, Mar 31, 2026FY2025, Dec 31, 2025
Revenue$249M$186M
Revenue growth3.4%−28.3%
Revenue growth a year, last 5 years13.2%−8.2%
Gross margin63.5%18.3%
Operating margin7.4%−115.9%
Net margin2.7%−70.4%
Free cash flow$40M−$71M
Free cash flow margin15.9%−38.1%
Return on capital4.8%−32.0%
Net debt to EBITDA1.0x—
Dividends and buybacks$4M$0M
Change in diluted share count2.7%4.7%
Last close$139.01$7.54
P/E at the last close120.9×—
Insider trades, last 12 months——
Piotroski F-score8 of 92 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Mesa LaboratoriesMaravai LifeSciences
Operating margin
Percent of revenue
Mesa LaboratoriesMaravai LifeSciences
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Mesa LaboratoriesMaravai LifeSciences

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Mesa Laboratories and Maravai LifeSciences pages.